slightly non-significantp = 0.874
The enhancement in VA was 0.22 ± 0.13 logMAR in the PL Group and 0.14 ± 0.10 logMAR in the Patching Group, with the PL Group showing a slightly non-significant higher increase in VA after one month ( p = 0.874).
The enhancement in VA was 0.22 ± 0.13 logMAR in the PL Group and 0.14 ± 0.10 logMAR in the Patching Group, with the PL Group showing a slightly non-significant higher increase in VA after one month ( p = 0.874).
It should be pointed out that at 18 months after treatment, VA of AE in the PL Group was worse compared to the Patching Group, although the difference did not reach statistical significance.
The most relevant improvement in VA and CS seems to occur in the first month after treatment and remains stable until 18 months later, but with an increasing trend.